Matthew S Davids

Author PubWeight™ 0.90^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Ibrutinib: a first in class covalent inhibitor of Bruton's tyrosine kinase.	Future Oncol	2014	0.98